Brief: Hansa Biopharma Q2 Net Income SEK -207.9 Million
18/07/2024 06:01
Jul 18 (Reuters) - Hansa Biopharma Q2 revenue SEK 34.3 million. * Q2 cash & investments SEK 705 million * Q2 adjusted EPS SEK -3.3 * Q2 EBIT SEK -187.4 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS